Get started
Author

Vullendula Sai Krishna Anand

Observed names: V. Anand, V. Sai Krishna Anand
ORCID: 0000-0002-0459-9159
Observed ORCID: 0000-0002-0459-9159
OpenAlex ID: A5017472290
Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology
2020 · Athira R. Nair, Yarlagadda Dani Lakshman, et al. · AAPS PharmSciTech · 193
PDF
Considerations for the selection of co-formers in the preparation of co-amorphous formulations
2021 · Dani Lakshman Yarlagadda, Vullendula Sai Krishna Anand, et al. · International Journal of Pharmaceutics · 75
The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials
2018 · V. Sai Krishna Anand, Sujata D. Sakhare, et al. · European Journal of Pharmaceutical Sciences · 45
A computational-based approach to fabricate Ceritinib co-amorphous system using a novel co-former Rutin for bioavailability enhancement
2023 · Dani Lakshman Yarlagadda, Vullendula Sai Krishna Anand, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 23
The Assessment of pH-Induced Supersaturation and Impact of an Additional Drug on the Solution Phase Behavior of Saquinavir
2018 · Sujata D. Sakhare, V. Sai Krishna Anand, et al. · Journal of Pharmaceutical Innovation · 11
Building the Great Wall Abroad: China's Security Engagement in Africa
2025 · Amrita Jash, V. Anand · IGI Global eBooks · 1
Physicochemical Interactions Between Concomitantly Administered Anti-Retroviral and Anti-Malarial Drug
2024 · Vullendula Sai Krishna Anand, Dani Lakshman Yarlagadda, et al. · Journal of Pharmaceutical Innovation · 1
Investigating the Impact of Calcium Channel Blockers on the Pharmacokinetics of Lapatinib: Possible Role of Cytochrome P450 Enzymes and P-glycoprotein Efflux Transporters
2026 · Mrunal Pradeep Desai, Prajakta Harish Patil, et al. · European Journal of Drug Metabolism and Pharmacokinetics
PDF
Works count: 8
Citation count: 349
H-index: 5
I10-index: 5
Year
Topic
Type